These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11117662)

  • 1. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study.
    Robinson KA
    Clin Ther; 2000 Nov; 22(11):1375-6. PubMed ID: 11117662
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Lu ML; Shen WW
    Ann Pharmacother; 2002; 36(7-8):1292; author reply 1292-3. PubMed ID: 12086567
    [No Abstract]   [Full Text] [Related]  

  • 3. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina.
    Sacristán JA; Gómez JC; Montejo AL; Vieta E; Gregor KJ
    Clin Ther; 2000 May; 22(5):583-99. PubMed ID: 10868556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
    Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.
    Sauriol L; Laporta M; Edwardes MD; Deslandes M; Ricard N; Suissa S
    Clin Ther; 2001 Jun; 23(6):942-56. PubMed ID: 11440294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.
    Fuller MA; Shermock KM; Secic M; Grogg AL
    Pharmacotherapy; 2003 Aug; 23(8):1037-43. PubMed ID: 12921249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
    Aubry JM; Simon AE; Bertschy G
    J Clin Psychiatry; 2000 Sep; 61(9):649-55. PubMed ID: 11030485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine-induced reversible priaprism: a case report.
    Deirmenjian JM; Erhart SM; Wirshing DA; Spellberg BJ; Wirshing WC
    J Clin Psychopharmacol; 1998 Aug; 18(4):351-3. PubMed ID: 9690708
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
    Gram LF
    Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome.
    Phan TG; Yu RY; Hersch MI
    Med J Aust; 1998 Aug; 169(4):230-1. PubMed ID: 9734590
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced mania in bipolar disorders.
    Henry C; Demotes-Mainard J
    J Psychiatry Neurosci; 2002 May; 27(3):200-1. PubMed ID: 12066449
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.
    Caro JJ; Ward A; Levinton C; Robinson K
    J Clin Psychiatry; 2002 Dec; 63(12):1135-9. PubMed ID: 12523873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.